Alchemia in Up to $240 Million Deal With AstraZeneca PLC (AZN) for VAST Discovery Platform
4/23/2013 6:46:25 AM
More...
|
Alchemia Announces Addition of Two Board Members
3/22/2013 8:59:37 AM
More...
|
Alchemia Granted Key U.S. Patent
3/6/2013 9:30:06 AM
More...
|
Alchemia Completes Enrolment in Pivotal Phase III HA-Irinotecan Trial of Metastatic Colorectal Cancer
2/28/2013 9:16:27 AM
More...
|
Alchemia Achieves $3.4 Million Quarterly Fondaparinux Profit Share
2/19/2013 9:06:49 AM
More...
|
Alchemia CFO Takes Over as CEO
2/19/2013 7:21:34 AM
More...
|
Alchemia Recruits First Patient to Pivotal Phase III Clinical Trial of HA-Irinotecan in Metastatic Colorectal Cancer
1/4/2012 8:45:39 AM
More...
|
Alchemia's Cancer Treatment Shows Early Promise in Lung Cancer Trial
9/28/2011 7:52:06 AM
More...
|
Alchemia Announces Initiation of Phase II Trial in Small Cell Lung Cancer
9/12/2011 10:27:54 AM
More...
|
Alchemia to Present at Cowen and Company 31st Annual Health Care Conference
3/4/2011 2:47:14 PM
More...
|
|